DILIC
MRNA icon

Dai-ichi Life Insurance Company’s Moderna MRNA Stock Holding History

Dai-ichi Life Insurance Company’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,673
Closed -$513K – 503
2024
Q3 		$513K Hold
7,673
– – 0.01% 457
2024
Q2 		$911K Buy
7,673
+5,000
+187% +$633K 0.02% 382
2024
Q1 		$285K Hold
2,673
– – 0.01% 433
2023
Q4 		$266K Sell
2,673
-13,000
-83% -$1.09M 0.01% 437
2023
Q3 		$1.62M Hold
15,673
– – 0.04% 310
2023
Q2 		$1.9M Sell
15,673
-218
-1% -$29.1K 0.04% 295
2023
Q1 		$2.44M Hold
15,891
– – 0.05% 268
2022
Q4 		$2.85M Buy
15,891
+2,678
+20% +$438K 0.07% 251
2022
Q3 		$1.56M Hold
13,213
– – 0.04% 320
2022
Q2 		$1.89M Hold
13,213
– – 0.04% 304
2022
Q1 		$2.28M Sell
13,213
-10,000
-43% -$1.68M 0.04% 327
2021
Q4 		$5.9M Buy
23,213
+12,000
+107% +$3.51M 0.08% 197
2021
Q3 		$4.32M Buy
11,213
+80
+0.7% +$29.5K 0.06% 232
2021
Q2 		$2.62M Hold
11,133
– – 0.03% 322
2021
Q1 		$1.46M Hold
11,133
– – 0.02% 388
2020
Q4 		$1.16M Sell
11,133
-10,000
-47% -$1.01M 0.02% 385
2020
Q3 		$1.5M Sell
21,133
-341
-2% -$23.8K 0.03% 345
2020
Q2 		$1.38M Buy
+21,474
New +$1.18M 0.03% 335

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Dai-ichi Life Insurance Company's MRNA Position: Q4 2024 in Review

Dai-ichi Life Insurance Company sold out of Moderna (MRNA) in Q4 2024, closing a stake of 7,673 shares — an estimated $513K sold.

Dai-ichi Life Insurance Company first reported a position in MRNA in Q2 2020 and held it in 18 quarters. The position peaked at $5.9M in Q4 2021. 746 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Dai-ichi Life Insurance Company reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Dai-ichi Life Insurance Company sold 7,673 Moderna shares in Q4 2024, an estimated $513K.
  • Dai-ichi Life Insurance Company first reported a position in Moderna in Q2 2020 and held it in 18 quarters.
  • Dai-ichi Life Insurance Company's Moderna position peaked at $5.9M in Q4 2021.
  • 746 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Dai-ichi Life Insurance Company's 13F filing for Q4 2024, filed 13 Feb 2025.